Healthcare advertising agency PRECISIONeffect launched INFLECTIONeffect, a data-driven discipline that amplifies the uptake of medical advances.

Stuart Goldstein was hired as chief operating officer at The Bloc, and Antoinette Bobbitt was promoted to executive VP, strategy director, at the agency. 

Publicis Groupe, one of the world’s largest communications groups, partnered with NewsGuard to provide clients with more responsible, trustworthy advertising platforms and content opportunities to combat the “infodemic” in media.

William D. Humphries was appointed CEO of Isosceles Pharmaceuticals Inc., a biotechnology company dedicated to developing, commercializing and marketing innovative non-opioid products for the treatment of mild-to-moderate pain and inflammatory diseases.

Karyopharm Therapeutics Inc. tapped Richard Paulson to be president and CEO.

Carmine Therapeutics Inc., an emerging leader in gene therapy, appointed Don Haut, Ph.D. as CEO and member of the board of directors.

Bantam Pharmaceutical, a drug discovery and development company targeting selective modulation of mitochondrial dynamics in cancer, named Michael Stocum as president and CEO.

The board of directors at Medivir AB tapped Magnus Christensen, the company’s chief financial officer, as interim CEO.

Biotech company Novavax Inc. promoted Gale E. Smith, Ph.D., to senior VP, discovery and pre-clinical research and chief scientist, and appointed Troy Morgan as senior VP, chief compliance officer.

Viome appointed Dr. Emmanuel Hanon as global head of research and development.